Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared with Tumor Necrosis Factor-α Inhibitors

Chul Hwan  Bang; Hyun Ju Oh; Yeong Ho Kim; Jin-Hyung Jung; Ji Hyun  Lee; Young Min Park; Ju Hee Han

doi:10.2340/actadv.v104.34206

Authors

Chul Hwan Bang Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea https://orcid.org/0000-0002-6246-0331
Hyun Ju Oh Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Yeong Ho Kim Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea https://orcid.org/0000-0003-4983-4906
Jin-Hyung Jung Department of Biostatistics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
Ji Hyun Lee Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea https://orcid.org/0000-0002-3671-502X
Young Min Park Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea https://orcid.org/0000-0002-3631-0807
Ju Hee Han Department of Dermatology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea https://orcid.org/0000-0003-3194-5202

DOI:

https://doi.org/10.2340/actadv.v104.34206

Keywords:

uveitis, psoriasis, anti-tumor necrosis factor-α antibody, ustekinumab

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Egeberg A, Khalid U, Gislason GH, Mallbris L, Skov L, Hansen PR. Association of psoriatic disease with uveitis: a Danish nationwide cohort study. JAMA Dermatol 2015; 151: 1200-1205.

https://doi.org/10.1001/jamadermatol.2015.1986 DOI: https://doi.org/10.1001/jamadermatol.2015.1986

Elmets CA, Leonardi CL, Davis DMR, Gelfand JM, Lichten J, Mehta NN, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 2019; 80: 1073-1113.

https://doi.org/10.1016/j.jaad.2018.11.058 DOI: https://doi.org/10.1016/j.jaad.2018.11.058

Kim BR, Choi SW, Choi CW, Lee KH, Kim MJ, Woo SJ, et al. Risk of uveitis in patients with psoriasis in Korea: a nationwide population-based cohort study. J Eur Acad Dermatol Venereol 2023; 37: 1336-1343.

https://doi.org/10.1111/jdv.19060 DOI: https://doi.org/10.1111/jdv.19060

Jadon DR, Corp N, van der Windt DA, Coates LC, Soriano ER, Kavanaugh A, et al. Management of concomitant inflammatory bowel disease or uveitis in patients with psoriatic arthritis: an updated review informing the 2021 GRAPPA Treatment Recommendations. J Rheumatol 2023; 50: 438-450.

https://doi.org/10.3899/jrheum.220317 DOI: https://doi.org/10.3899/jrheum.220317

Singla S, Putman M, Liew J, Gordon K. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study. Lancet Rheumatol 2023; 5: e200-e207.

https://doi.org/10.1016/S2665-9913(23)00034-6 DOI: https://doi.org/10.1016/S2665-9913(23)00034-6

Han JH, Park HE, Kim YH, Jung JH, Lee JH, Park YM, et al. Comparison of the risk of heart failure in psoriasis patients using anti-TNF α inhibitors and ustekinumab. ESC Heart Fail 2022; 9: 1502-1504.

https://doi.org/10.1002/ehf2.13855 DOI: https://doi.org/10.1002/ehf2.13855

Kose B, Uzlu D, Erdol H. Psoriasis and uveitis. Int Ophthalmol 2022; 42: 2303-2310.

https://doi.org/10.1007/s10792-022-02225-5 DOI: https://doi.org/10.1007/s10792-022-02225-5